International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk, Brenda Banwell, Jeffrey L. Bennett, Philippe Cabre, William M Carroll, Tanuja Chitnis, Jerome De Seze, Kazuo Fujihara, Benjamin M. Greenberg, Anu Jacob, Sven Jarius, Marco Aurélio Lana–Peixoto, Michael Levy, Jack H. Simon, Silvia Tenembaum, Anthony L. Traboulsee, Patrick Joseph Waters, Kay E. Wellik, Brian G. Weinshenker
Neurology · 2015 · 4,744 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Wingerchuk, D. M., Banwell, B., Bennett, J. L., Cabre, P., Carroll, W. M., Chitnis, T., Seze, J. D., Fujihara, K., Greenberg, B. M., Jacob, A., Jarius, S., Lana–Peixoto, M. A., Levy, M., Simon, J. H., Tenembaum, S., Traboulsee, A. L., Waters, P. J., Wellik, K. E., & Weinshenker, B. G. (2015). International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology, 85(2), 177–189. https://doi.org/10.1212/wnl.0000000000001729
In text: (Wingerchuk et al., 2015)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
Neuromyelitis optica (NMO) is an inflammatory CNS syndrome distinct from multiple sclerosis (MS) that is associated with serum aquaporin-4 immunoglobulin G antibodies (AQP4-IgG). Prior NMO diagnostic criteria required optic nerve and spinal cord involvement but more restricted or more extensive CNS involvement may occur. The International Panel for NMO Diagnosis (IPND) was convened to develop revised diagnostic criteria using systematic literature reviews and electronic surveys to facilitate consensus. The new nomenclature defines the unifying term NMO spectrum disorders (NMOSD), which is stratified further by serologic testing (NMOSD with or without AQP4-IgG). The core clinical characteristics required for patients with NMOSD with AQP4-IgG include clinical syndromes or MRI findings related to optic nerve, spinal cord, area postrema, other brainstem, diencephalic, or cerebral presentations. More stringent clinical criteria, with additional neuroimaging findings, are required for diagnosis of NMOSD without AQP4-IgG or when serologic testing is unavailable. The IPND also proposed validation strategies and achieved consensus on pediatric NMOSD diagnosis and the concepts of monophasic NMOSD and opticospinal MS.
Related papers
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides2012
- Ranibizumab for Neovascular Age-Related Macular Degeneration2006
- 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts2016
Metadata from OpenAlex (CC0). Citations are generated from the published record.